According to Newswise, the Omar Boraie Chair in Genomic Science was established at Rutgers University.
Rutgers University now has a new academic chair, and it was named after the prominent real estate developer Omar Boraie. Boraie, who has had an interest in cancer research for many years, made a pledge of supporting the new chair with more than $1.5 million in order to enhance the field of precision medicine. The chair was too part of a program that consisted of other 17 academic chairs. According to Patch, the campaign program, however, would have not been possible without the help of an anonymous individual, who donated about $3 million to each chair.
Thanks to genomic sequencing and precision medicine, physicians have been able to analyze tumors on a genetic level. Thus, through genomic analysis, oncologists can prescribe tailored diagnoses and therapies. Precision medicine, though still quite a new field, has received a lot of attention on behalf of the scientific community. It was even recognized by the then President Barack Obama.
The business magnate, in this case, perhaps focused on Rutgers Cancer Institute because of its genuine concentration on genomic sequencing. For instance, the Cancer Institute of New Jersey was the first facility in its state to apply genomic sequencing as a precision medicine approach. Through genomic sequencing, oncologists, for example, have found better treatments for patients with rare types of cancers. Others have become immune to conventional treatments, and they have also benefited from genomic analysis.
According to Boraie, who also has a rigorous background in chemistry, the scientists and physicians from Rutgers Cancer Institute (http://magazine.rutgers.edu/insights/seeing-the-future) have contributed a lot to the field of precision medicine, and many cancer patients have benefited from their efforts. Boraie also hopes that he has influenced other affluent individuals. The business magnate, after all, was too influenced by the anonymous individual. Robert S. DiPaola, the current director of Rutgers Cancer Institute, thinks that Boraie’s contributions will leave a great legacy. Boraie’s actions will greatly impact cancer research.
The physician-scientist and professor of medicine Shridar Ganesan was nominated for the prestigious chair. According to Ganesan, Boraie’s pledge will bring new understandings in the field of cancer biology, and there will be new hope for cancer patients from all parts of the world. Ganesan also thinks that there is still a lot to learn about tumors. Cancer is rather a collection of diseases, and through genomic analysis, oncologists can create better classification systems.
To learn more about Omar, visit his crunchbase.com bio.